Role of α1‐blockers in the current management of hypertension
Abstract There is emerging evidence that α1‐blockers can be safely used in the treatment of hypertension. These drugs can be used in almost all hypertensive patients for blood pressure control. However, there are several special indications. Benign prostatic hyperplasia is a compelling indication of...
Main Authors: | Hua Li, Ting‐Yan Xu, Yan Li, Yook‐Chin Chia, Peera Buranakitjaroen, Hao‐Min Cheng, Minh Van Huynh, Guru Prasad Sogunuru, Jam Chin Tay, Tzung‐Dau Wang, Kazuomi Kario, Ji‐Guang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | The Journal of Clinical Hypertension |
Subjects: | |
Online Access: | https://doi.org/10.1111/jch.14556 |
Similar Items
-
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Wei‐Chieh Huang, et al.
Published: (2022-09-01) -
Targets and management of hypertension in heart failure: focusing on the stages of heart failure
by: Huanhuan Miao, et al.
Published: (2022-09-01) -
Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
by: G Agnes Golda Priyadarshini, et al.
Published: (2023-01-01) -
Characteristics of hypertension in obstructive sleep apnea: An Asian experience
by: Satoshi Hoshide, et al.
Published: (2021-03-01) -
Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
by: Huynh Van Minh, et al.
Published: (2021-03-01)